Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | €704.90 | €766.92 | 8.798% |
| Boston Scientific | 46 | 0 | 13 | 0 | €67.50 | €72.96 | 8.084% |
| Biogen Inc. | 44 | 2 | 4 | 1 | €198.80 | €293.57 | 47.672% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €372.90 | €382.71 | 2.629% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €140.00 | €228.30 | 63.071% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | €874.40 | €957.22 | 9.472% |
| Intuitive Surgical Inc | 34 | 0 | 4 | 0 | €352.15 | €370.00 | 5.069% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €459.85 | €543.72 | 18.239% |
| Johnson & Johnson | 32 | 1 | 2 | 0 | €139.78 | €196.74 | 40.747% |
| Pfizer Inc. | 31 | 4 | 3 | 1 | €25.83 | €41.10 | 59.129% |
| Tenet Healthcare | 28 | 0 | 7 | 0 | €111.00 | €118.36 | 6.635% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €119.60 | €124.93 | 4.456% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.30 | €140.34 | 7.705% |
| Thermo Fisher Scientific Inc. | 27 | 0 | 6 | 0 | €532.60 | €568.09 | 6.664% |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €79.31 | €87.48 | 10.295% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €60.50 | €83.81 | 38.537% |
| Humana Inc. | 23 | 0 | 5 | 0 | €299.30 | €439.88 | 46.968% |
| Stryker Corp. | 23 | 0 | 10 | 0 | €304.50 | €335.03 | 10.026% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €66.00 | €79.43 | 20.348% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.30 | €28.06 | 83.404% |
| HCA Holdings Inc. | 22 | 0 | 6 | 0 | €287.90 | €294.53 | 2.301% |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| Amgen Inc. | 21 | 0 | 3 | 0 | €259.65 | €294.28 | 13.338% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.92 | €174.43 | 16.351% |
| Zoetis Inc. A | 21 | 1 | 3 | 1 | €155.90 | €200.06 | 28.324% |